A recent American Society of Anesthesiologists survey shows an escalating interest in marijuana for managing pain among U.S. adults, but the ASA warns more...
Despite Curaleaf reporting wider losses and lower-than-expected revenues in the second-quarter, investors remained upbeat on its more than US$1-billion revenue guidance for 2020.